title: [Intensified blood glucose control in type 1 diabetic patients - what are the target levels?].
authors.affiliation: 1 Département de médecine interne Hôpital cantonal HFR-Fribourg.
authors.forename: Remco
authors.initials: R
authors.lastname: Kruithof
authors.affiliation: 2 Cochrane Schweiz, Institut universitaire de médecine sociale et préventive, Lausanne.
authors.forename: Aline
authors.initials: A
authors.lastname: Flatz
authors.affiliation: 2 Cochrane Schweiz, Institut universitaire de médecine sociale et préventive, Lausanne.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Peytremann-Bridevaux
authors.affiliation: 3 Centre médical d'Epalinges.
authors.forename: Marc
authors.initials: M
authors.lastname: Egli
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000097:blood / Q000401:mortality / Q000628:therapy; D015190:Blood Glucose Self-Monitoring / Q000379:methods*; D048909:Diabetes Complications / Q000097:blood / Q000401:mortality / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000401:mortality / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000097:blood / Q000401:mortality / Q000628:therapy; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015996:Survival Rate
chemical_list: D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human